BTI
RIGL icon

Blue Trust Inc’s Rigel Pharmaceuticals RIGL Stock Holding History

Blue Trust Inc’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50
Closed -$899 – 2582
2025
Q1 		$899 Hold
50
– – ﹤0.01% 2309
2024
Q4 		$841 Hold
50
– – ﹤0.01% 2296
2024
Q3 		$411 Sell
50
-450
-90% -$5.29K ﹤0.01% 2810
2024
Q2 		$740 Buy
500
+450
+900% +$4.71K ﹤0.01% 2574
2024
Q1 		$740 Hold
50
– – ﹤0.01% 1980
2023
Q4 		$1K Hold
50
– – ﹤0.01% 2397
2023
Q3 		$1K Hold
50
– – ﹤0.01% 1956
2023
Q2 		$1K Hold
50
– – ﹤0.01% 1911
2023
Q1 		$1K Hold
50
– – ﹤0.01% 2198
2022
Q4 		$1K Hold
50
– – ﹤0.01% 2123
2022
Q3 		$1K Hold
50
– – ﹤0.01% 1996
2022
Q2 		$1K Buy
+50
New +$1K ﹤0.01% 1821

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Blue Trust Inc's RIGL Position: Q2 2025 in Review

Blue Trust Inc sold out of Rigel Pharmaceuticals (RIGL) in Q2 2025, closing a stake of 50 shares — an estimated $899 sold.

Blue Trust Inc first reported a position in RIGL in Q2 2022 and held it in 12 quarters. The position peaked at $1K in Q4 2023. 125 funds tracked by Wall St. Rank hold RIGL as of Q2 2025.

  • Blue Trust Inc reported no remaining Rigel Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Blue Trust Inc sold 50 Rigel Pharmaceuticals shares in Q2 2025, an estimated $899.
  • Blue Trust Inc first reported a position in Rigel Pharmaceuticals in Q2 2022 and held it in 12 quarters.
  • Blue Trust Inc's Rigel Pharmaceuticals position peaked at $1K in Q4 2023.
  • 125 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2025.

Based on Blue Trust Inc's 13F filing for Q2 2025, filed 24 Jul 2025.